Cargando…
Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
BACKGROUND: Despite limited and conflicting data on the use of hydroxychloroquine in patients with Covid-19, the U.S. Food and Drug Administration has authorized the emergency use of this drug when clinical trials are unavailable or infeasible. Hydroxychloroquine, alone or in combination with azithr...
Autores principales: | Magagnoli, Joseph, Narendran, Siddharth, Pereira, Felipe, Cummings, Tammy, Hardin, James W., Sutton, S. Scott, Ambati, Jayakrishna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276049/ https://www.ncbi.nlm.nih.gov/pubmed/32511622 http://dx.doi.org/10.1101/2020.04.16.20065920 |
Ejemplares similares
-
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19
por: Magagnoli, Joseph, et al.
Publicado: (2020) -
Association between Fluoxetine Use and Overall Survival among Patients with Cancer Treated with PD-1/L1 Immunotherapy
por: Magagnoli, Joseph, et al.
Publicado: (2023) -
The Association between the Use of Proton Pump Inhibitors and the Risk of
Hypomagnesemia in a National Cohort of Veteran Patients with HIV
por: Sutton, S. Scott, et al.
Publicado: (2019) -
Inpatient, Outpatient, and Pharmacy Costs in Patients With and Without HIV in the US Veteran’s Affairs Administration System
por: Sutton, Scott, et al.
Publicado: (2019) -
Odds of Acute Kidney Injury in Patients Receiving Dipeptidyl Peptidase 4 Inhibitors: A National Cohort Study Within the Department of Veterans Affairs
por: Sutton, S. Scott, et al.
Publicado: (2019)